Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation.

Molecular therapy. Advances·2026
Same author

Effects of cellular receptors on the vaccine efficacies of adenovirus vector-based vaccines following intramuscular and intranasal administration.

Scientific reports·2026
Same author

Liver-Specific Suppression of PLA2G6/iPLA<sub>2</sub>β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

[Association between the Risk of Drug-induced Liver Injury and the Reactive Metabolites Acyl Glucuronides].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2026
Same author

Oncolytic Reovirus-Induced Prostaglandin E2 Production in Human Tumor Cells.

Biological & pharmaceutical bulletin·2025
Same author

Oncolytic adenovirus serotype 35 mediated tumor growth suppression <i>via</i> efficient activation of antitumor immunity.

Journal for immunotherapy of cancer·2025

Related Experiment Video

Updated: Jul 17, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production.

Naoya Koizumi1, Tomoko Yamaguchi, Kenji Kawabata

  • 1Laboratory of Gene Transfer and Regulation, National Institute of Biomedical Innovation, Osaka, Japan.

Journal of Immunology (Baltimore, Md. : 1950)
|January 24, 2007
PubMed
Summary

A modified Adenovirus (Ad) vector with fiber-knob poly-lysine peptides significantly reduced serum IL-6 and liver toxicity. This safer gene therapy vector also showed reduced spleen distribution and cytokine expression.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Related Experiment Videos

Last Updated: Jul 17, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Area of Science:

  • Immunology
  • Gene Therapy
  • Virology

Background:

  • Adenovirus (Ad) vectors are widely used in gene therapy but trigger significant innate immune and inflammatory responses.
  • Improving the safety and therapeutic index of Ad vector gene therapy necessitates understanding Ad vector-induced inflammation and cytokine production.

Purpose of the Study:

  • To investigate the immune response and liver toxicity of a novel fiber-modified Ad vector.
  • To elucidate the mechanisms underlying Ad vector-induced inflammation and identify strategies for safer gene therapy vectors.

Main Methods:

  • Systemic administration of conventional and fiber-modified Ad vectors in vivo.
  • Measurement of serum cytokines (e.g., IL-6) and liver enzymes (aspartate aminotransferase).
  • RT-PCR analysis of cytokine, chemokine, and IFN expression in spleen and liver; identification of cytokine-secreting splenic CD11c(+) cells; assessment of Ad vector DNA distribution; evaluation of liver toxicity reduction using anti-IL-6R antibody.

Main Results:

  • The fiber-modified Ad vector exhibited lower serum IL-6 and aspartate aminotransferase levels compared to the conventional Ad vector.
  • Despite reduced toxicity, the modified vector showed enhanced transgene production in the liver.
  • Spleen, not liver, was identified as the primary site for cytokine, chemokine, and IFN expression, with splenic CD11c(+) cells secreting cytokines.
  • Reduced spleen distribution of the modified Ad vector correlated with lower serum IL-6 levels.
  • Anti-IL-6 receptor antibody treatment reduced liver toxicity caused by the conventional Ad vector, indicating IL-6 signaling's role.

Conclusions:

  • The fiber-modified Ad vector demonstrates reduced innate immunity and liver toxicity, offering a safer alternative for gene therapy.
  • Reduced IL-6 production and signaling are key mechanisms contributing to the decreased liver toxicity of the modified vector.
  • Understanding the splenic immune response to systemically administered Ad vectors is crucial for designing improved and safer gene therapy strategies.